Ravi Vij & Dr. Natalie Callander MD discusses on Anitocabtagene Autoleuce (Anitocel) in R/R MM
Автор: MyCancerHaven for Healthcare Professionals
Загружено: 2026-03-09
Просмотров: 20
Описание:
In this expert conversation, they explore the science behind Anitocel, its clinical development, and how this next-generation CAR-T cell therapy could impact treatment outcomes for patients with relapsed or refractory multiple myeloma. The discussion also highlights key clinical insights, potential benefits, and the future direction of CAR-T therapies in myeloma care.
This video is valuable for oncologists, hematologists, medical professionals, and researchers interested in the latest advances in multiple myeloma treatment and cellular therapies.
🔔 Subscribe to our channel for more expert discussions and updates on cutting-edge oncology treatments.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
